Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity

Roberta L Keller1, Theresa A Tacy, Karen Hendricks-Munoz

  • 1Department of Pediatrics, University of California San Francisco, 94143, USA. kellerr@peds.ucsf.edu

Insights

Infants with congenital diaphragmatic hernia (CDH) and poor outcomes show higher endothelin-1 (ET1) levels and pulmonary hypertension (PH) severity. ET1 levels correlate with PH severity in these infants.

Area of Science:

  • Neonatal research
  • Pediatric cardiology
  • Pulmonary hypertension research

Background:

  • Endothelin-1 (ET1) is implicated in pulmonary hypertension (PH) and may play a role in congenital diaphragmatic hernia (CDH) pathobiology.
  • Investigating ET1 in CDH is crucial for understanding disease progression and outcomes.

Purpose of the Study:

  • To determine if ET1 levels in the first month are higher in CDH infants with poor outcomes (mortality or oxygen dependence at discharge).
  • To assess the association between ET1 levels and the severity of PH in infants with CDH.

Main Methods:

  • Plasma ET1 levels were measured in 40 newborns with CDH at 24-48 hours, and 1, 2, and 4 weeks of age.
  • Echocardiograms were used to estimate pulmonary artery pressure and classify PH severity weekly up to 4 weeks.

Main Results:

  • Higher ET1 levels at 1 and 2 weeks were observed in CDH infants with poor outcomes compared to those discharged on room air (P=0.03 and P=0.01, respectively).
  • PH severity was significantly associated with increasing ET1 levels at 2 weeks (P=0.03).
  • Increased PH severity also correlated with poor outcomes (P=0.001).

Conclusions:

  • CDH infants experiencing poor outcomes exhibit elevated plasma ET1 levels and greater PH severity.
  • Plasma ET1 levels are associated with PH severity in infants with CDH.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Hiatal Hernia01:25

Hiatal Hernia

A hiatal hernia is the abnormal protrusion of the stomach or other abdominal organs through the esophageal hiatus of the diaphragm into the thoracic cavity.Normally, the gastroesophageal junction (GEJ) lies below the diaphragm and is supported by the phrenoesophageal membrane, the diaphragmatic crura, and connective tissues. Weakening of these structures—due to aging, congenital defects like a short esophagus, or increased intra-abdominal pressure from coughing, obesity, pregnancy, or heavy...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...